Fantuzzi G, Cantoni L, Sironi M, Ghezzi P
Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Cell Immunol. 1993 Sep;150(2):417-24. doi: 10.1006/cimm.1993.1209.
We tested the effect of different inhibitors of cytochrome P450 on tumor necrosis factor (TNF) production. Metyrapone and SKF525A (100 and 50 mg/kg, ip, respectively) suppressed serum TNF induced by cotreatment with endotoxin (LPS), (2.5 micrograms/mouse). Inhibition was independent of endogenous corticosteroids since it was also observed in adrenalectomized mice. In vitro production of TNF by endotoxin-stimulated human monocytes was also inhibited by metyrapone and SKF525A. Since lipoxygenase (LO) inhibitors also block TNF production and metyrapone was reported to inhibit LO, we suggest that inhibition by metyrapone and SKF525A might be due to inhibition of either LO or a cytochrome P450 implicated in the oxidation of endogenous substrates involved in the inflammatory response.
我们测试了不同细胞色素P450抑制剂对肿瘤坏死因子(TNF)产生的影响。甲吡酮和SKF525A(分别为100和50mg/kg,腹腔注射)抑制了与内毒素(LPS,2.5微克/只小鼠)联合处理诱导的血清TNF。这种抑制与内源性皮质类固醇无关,因为在肾上腺切除的小鼠中也观察到了这种抑制。甲吡酮和SKF525A也抑制了内毒素刺激的人单核细胞在体外产生TNF。由于脂氧合酶(LO)抑制剂也能阻断TNF的产生,且据报道甲吡酮能抑制LO,我们认为甲吡酮和SKF525A的抑制作用可能是由于抑制了LO或参与炎症反应的内源性底物氧化的细胞色素P450。